本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

SpringWorks Therapeutics, Inc.

44.93
+3.729.03%
盤後44.94-0.0392-0.09%19:59 EDT
成交量:886.77萬
成交額:3.95億
市值:33.69億
市盈率:-12.90
高:46.21
開:41.26
低:40.47
收:41.21
資料載入中...

公司資料

公司名字:
SpringWorks Therapeutics, Inc.
交易所:
NASDAQ
成立時間:
2017
員工人數:
368
公司地址:
100 Washington Boulevard,Stamford,Connecticut,United States
郵編:
06902
電話:
傳真:
- -
簡介:
SpringWorks Therapeutics, Inc.於2017年8月在特拉華州成立。該公司是一家臨床階段的生物製藥公司,使用精密醫學來為患有嚴重疾病和癌症的服務不足的患者人群獲取,開發和商品化改變生命的藥物。

董事

名稱
職位
Daniel S. Lynch
Chairman of the Board
Saqib Islam
Chief Executive Officer and Director
Stephen Squinto
Director and Acting Head of Research and Development
Alan Fuhrman
Director
Carl L. Gordon
Director
Deval L. Patrick
Director
Freda Lewis Hall
Director
Jeffrey Schwartz
Director

股東

名稱
職位
Saqib Islam
Chief Executive Officer and Director
Francis I. Perier, Jr.
Chief Financial Officer
L. Mary Smith
Senior Vice President, Clinical Research and Development
Badreddin Edris
Chief Business Officer
Jens Renstrup
Chief Medical Officer
Michael V. Greco
General Counsel and Secretary
Stephen Squinto
Director and Acting Head of Research and Development